MedTrace Logo

Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery

NCT01097265 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 1500

Last updated 2013-08-12

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures such as sentinel lymph node mapping may help doctors find patients who are at risk of developing micrometastases and plan better treatment.

PURPOSE: This randomized phase II/III trial is studying micrometastases in patients with stage I or stage II localized colon cancer that can be removed by surgery.

Conditions

Interventions

DRUG

capecitabine

DRUG

oxaliplatin

OTHER

active surveillance

OTHER

laboratory biomarker analysis

PROCEDURE

adjuvant therapy

PROCEDURE

lymph node mapping

PROCEDURE

sentinel lymph node biopsy

Sponsors & Collaborators

  • Jeroen Bosch Ziekenhuis

    lead OTHER

Principal Investigators

  • Koop Bosscha, MD · Jeroen Bosch Ziekenhuis

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2015-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01097265 on ClinicalTrials.gov